top of page

BILAXTEN ORODISPERSIBLE TABLET 10MG

Product details

Registration number: SIN15874P

Classification: Prescription Only

Active ingredients: BILASTINE

Strength: 10MG/TABLET

Dosage form: TABLET, ORALLY DISINTEGRATING

Route: ORAL

Registrant: A. MENARINI SINGAPORE PTE. LTD.

ATC code: R06AX29

HSA approval date: 13 January 2020

Manufacturer(s): A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for BILAXTEN ORODISPERSIBLE TABLET 10MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15874P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for BILAXTEN ORODISPERSIBLE TABLET 10MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: BILASTINE

Strength: 10MG/TABLET

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for BILAXTEN ORODISPERSIBLE TABLET 10MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, ORALLY DISINTEGRATING

Route: ORAL

Source for this answer

Who is the recorded registrant for BILAXTEN ORODISPERSIBLE TABLET 10MG?

According to the HSA dataset updated 7 August 2026:

Registrant: A. MENARINI SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for BILAXTEN ORODISPERSIBLE TABLET 10MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up BILAXTEN ORODISPERSIBLE TABLET 10MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15874P or the exact product name BILAXTEN ORODISPERSIBLE TABLET 10MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this BILAXTEN ORODISPERSIBLE TABLET 10MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this BILAXTEN ORODISPERSIBLE TABLET 10MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15874P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page